PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has announced its participation in the upcoming European Alliance of Associations for Rheumatology (EULAR) 2025 Congress, set to take place from June 11-14 at Fira de Barcelona in Spain. The company will present new data highlighting progress in its preclinical cell therapy pipeline and investigative programs targeting autoimmune diseases and cancer.
The presentations will showcase Century’s innovative approach leveraging induced pluripotent stem cells (iPSCs) as the foundation for off-the-shelf therapies aimed at addressing complex conditions. Key details are as follows:
- Abstract Number 1380
Title: CNTY-101, an iPSC-Derived Allogeneic CD19 Targeting CAR-NK Product, Exhibits Robust B Cell Depletion and Has Broad Potential for Development in B Cell-Driven Autoimmune Diseases
Presentation Type: Poster Tour
Session Date/Time: Thursday, June 12, 2025, 9:30 a.m.–9:36 a.m. CEST
Presenter: Hongxia Zhang, Ph.D., Director of Translational Development - Abstract Number 2099
Title: Generation of iPSC-Derived CAR-NK, γδ CAR-T, and αβ CAR-T Cells with Potent Activity for Treatment of B cell-mediated Autoimmune Diseases
Presentation Type: Poster Tour
Session Date/Time: Thursday, June 12, 2025, 9:42 a.m.–9:48 a.m. CEST
Presenter: Jonathan Kurtz, Ph.D., Director of Molecular Immunology
The data covers key developments in CNTY-101, an allogeneic CD19-targeting CAR-NK product, which demonstrates strong B cell depletion capabilities and potential applications in B cell-driven autoimmune diseases. Additionally, insights into Century’s pipeline of iPSC-derived CAR-NK and CAR-T cells for B cell-mediated conditions will be provided, reflecting the company’s commitment to addressing unmet medical needs in immune-related diseases.
Century Therapeutics advances its platform to create potent, scalable, and targeted cell therapies. Presentations at EULAR 2025 highlight the company’s efforts in iPSC-based therapies and dedication to improving outcomes for patients with autoimmune diseases and cancers.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.